BiotechTube
Home/Nano24med/Jeffrey Glenn
JG

Jeffrey Glenn

MD, PhD

Nano24med

Therapeutic Areas

ImmunologyRespiratory DiseasesCritical Care

Nano24med Pipeline

DrugIndicationPhase
EXO‑CD24Acute Respiratory Distress Syndrome (ARDS)Phase 2

Leadership Team at Nano24med

PN
Prof. Nadir Arber
CMO, Founder
DS
Dr. Shiran Shapira
CSO, Founder
PJ
Prof. Jürgen Rockstroh
MD
TW
Tim Wessel
PhD
MS
Michael Schickler
PhD
PN
Prof. Neville Berkman
MD
YS
Yossi Sela
Director
DG
Dr. Gadi Ben‑Ari
MD
BR
Ben Rothschild
Advisor
DM
Dr. Mira Peled
PhD
View full Nano24med profile